Kelly Financial Services’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-33
| Closed | -$63 | – | 146 |
|
|
2024
Q2 | $63 | Hold |
33
| – | – | ﹤0.01% | 764 |
|
|
2024
Q1 | $94 | Hold |
33
| – | – | ﹤0.01% | 754 |
|
|
2023
Q4 | $486 | Hold |
33
| – | – | ﹤0.01% | 707 |
|
|
2023
Q3 | $604 | Hold |
33
| – | – | ﹤0.01% | 669 |
|
|
2023
Q2 | $712 | Hold |
33
| – | – | ﹤0.01% | 630 |
|
|
2023
Q1 | $968 | Hold |
33
| – | – | ﹤0.01% | 597 |
|
|
2022
Q4 | $1.22K | Hold |
33
| – | – | ﹤0.01% | 553 |
|
|
2022
Q3 | $929 | Buy |
+33
| New | +$929 | ﹤0.01% | 575 |
|